For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240523:nRSW7131Pa&default-theme=true
RNS Number : 7131P Marlowe PLC 23 May 2024
23 May 2024
Marlowe plc
Exercise of Share Options
Total Voting Rights
Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical
services, announces that, as a result of an exercise of employee share
options, application has been made for 92,975 new ordinary shares of 50 pence
each in the Company (the "New Ordinary Shares") to be admitted to trading on
AIM.
The New Ordinary Shares will rank pari passu with the Company's existing
ordinary shares and it is expected that admission will occur at 8.00 a.m. on
30 May 2024.
Following admission of the New Ordinary Shares, the Company's issued ordinary
share capital will comprise 96,950,606 ordinary shares, none of which are held
in treasury. Therefore, the total number of ordinary shares with voting rights
in Marlowe following admission will be 96,950,606.
The above figure of 96,950,606 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the Company under
the FCA's Disclosure Guidance and Transparency Rules.
For further information:
Marlowe plc
Alex Dacre, Chief Executive www.marloweplc.com (http://www.marloweplc.com)
Adam Councell, Chief Financial Officer Tel: +44 (0) 203 813 8498
Benjamin Tucker, Head of Investor Relations
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)
Ben Jeynes Tel: +44 (0)20 7220 0500
George Lawson
Investec Bank plc (Joint Broker)
Henry Reast Tel: +44 (0)20 7597 5970
Oliver Cardigan
FTI Consulting
Nick Hasell Tel: +44 (0)20 3727 1340
Alex Le May
About Marlowe plc
Marlowe is a leader in business-critical services which ensures compliance
with strict regulations and insurance requirements across Fire Safety &
Security, Water & Air Hygiene and Occupational Health. The Gorup has a
national footprint and serves over 30,000 customers across office complexes,
high streets & leisure facilities, manufacturing plants and industrial
estates, and include thousands of SMEs, local authorities, facilities
management providers, multi-site NHS trusts and FTSE 100 companies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEPPURCAUPCGWW